Downregulation Of 14q32 Micrornas In Primary Human Desmoplastic Medulloblastoma

Medulloblastoma (MB) is one of the most common pediatric cancers, likely originating from abnormal development of cerebellar progenitor neurons. MicroRNA (miRNA) has been shown to play an important role in the development of the central nervous system. Microarray analysis was used to investigate miRNA expression in desmoplastic MB from patients diagnosed at a young age (1 or 2 years old). Normal fetal or newborn cerebellum was used as control. A total of 84 differentially expressed miRNAs (64 downregulated and 20 upregulated) were found. Most downregulated miRNAs (32/64) were found to belong to the cluster of miRNAs at the 14q32 locus, suggesting that this miRNA locus is regulated as a module in MB. Possible mechanisms of 14q32 miRNAs downregulation were investigated by the analysis of publicly available gene expression data sets. First, expression of estrogen-related receptor-γ (ESRRG), a reported positive transcriptional regulator of some 14q32 miRNAs, was found downregulated in desmoplastic MB. Second, expression of the parentally imprinted gene MEG3 was lower in MB in comparison to normal cerebellum, suggesting a possible epigenetic silencing of the 14q32 locus. miR-129-5p (11p11.2/7q32.1), miR-206 (6p12.2), and miR-323-3p (14q32.2), were chosen for functional studies in DAOY cells. Overexpression of miR-129-5p using mimics decreased DAOY proliferation. No effect was found with miR-206 or miR-323 mimics. © 2013 Lucon, Rocha, Craveiro, Dilloo, Cardinalli, Cavalcanti, Aguiar, Maurer-Morelli and Yunes.3 SEPEllison, D., Classifying the medulloblastoma: insights from morphology and molecular genetics (2002) Neuropathol Appl Neurobiol, 28, pp. 257-282. , doi:10.1046/j.1365-2990.2002.00419.xGulino, A., Di Marcotullio, L., Ferretti, E., De Smaele, E., Screpanti, I., Hedgehog signaling pathway in neural development and disease (2007) Psychoneuroendocrinology, 32, pp. S25-56. , doi:10.1016/j.psyneuen.2007.03.017Kool, M., Koster, J., Bunt, J., Hasselt, N.E., Lakeman, A., van Sluis, P., Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features (2008) PLoS ONE, 3, pp. e3088. , doi:10.1371/journal.pone.0003088Northcott, P.A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C.G., Mack, S., Medulloblastoma comprises four distinct molecular variants (2010) J Clin Oncol, 29, pp. 1408-1414. , doi:10.1200/JCO.2009.27.4324Gilbertson, R.J., Ellison, D.W., The origins of meduloblastoma subtypes (2008) Annu Rev Pathol, 3, pp. 341-365. , doi:10.1146/annurev.pathmechdis.3.121806.151518Schüller, U., Heine, V.M., Mao, J., Kho, A.T., Dillon, A.K., Han, Y.G., Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form SHH-induced medulloblastoma (2008) Cancer Cell, 14, pp. 123-134. , doi:10.1016/j.ccr.2008.07.005Yang, Z.J., Ellis, T., Markant, S.L., Read, T.A., Kessler, J.D., Bourboulas, M., Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells (2008) Cancer Cell, 14 (2), pp. 135-145. , doi:10.1016/j.ccr.2008.07.003Gibson, P., Tong, Y., Robinson, G., Thomson, M.C., Currie, D.S., Eden, C., Subtypes of medulloblastoma have distinct developmental origins (2010) Nature, 468, pp. 1095-1099. , doi:10.1038/nature09587Cohen, S.M., (2010) MiRNAs in CNS Development and Neurodegeneration: Insights from Drosophila Genetics, , http://www.springer.com/978-3-642-04297-3, Springer Available fromSood, P., Krek, A., Zavolan, M., Macino, G., Rajewsky, N., Cell-type-specific signatures of microRNAs on target mRNA expression (2006) Proc Natl Acad Sci U S A, 103 (8), pp. 2746-2751. , doi:10.1073/pnas.0511045103Guo, H., Ingolia, N.T., Weissman, J.S., Bartel, D.P., Mammalian microRNAs predominantly act to decrease target mRNA levels (2010) Nature, 466 (7308), pp. 835-841. , doi:10.1038/nature09267Ferretti, E., De Smaele, E., Po, A., Di Marcotullio, L., Tosi, E., Espínola, M.S.B., MiRNA profiling in human meduloblastoma (2009) Int J Cancer, 124, pp. 568-577. , doi:10.1002/ijc.23948Northcott, P.A., Fernandez, L.A., Hagan, J.P., Ellison, D.W., Grajkowska, W., Gillespie, Y., The miR-17/92 polycistron is upregulated in Sonic Hedgehog driven medulloblastomas and induced by N-myc in Sonic Hedgehog-treated cerebellar neural precursors (2009) Cancer Res, 69, pp. 3249-3255. , doi:10.1158/0008-5472.CAN-08-4710Cho, Y.J., Tsherniak, A., Tamayo, P., Santagata, S., Ligon, A., Greulich, H., Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome (2011) J Clin Oncol, 29 (11), pp. 1424-1430. , doi:10 1200/JCO. 2010. 28. 5148Fernandez, L.A., Northcott, P.A., Taylor, M.D., Kenney, A.M., Normal and oncogenic roles for microRNAs in the developing brain (2009) Cell Cycle, 8 (24), pp. 4049-4054. , doi:10.4161/cc.8.24.10243Pfister, S.M., Korshunov, A., Kool, M., Hasselblatt, M., Eberhart, C., Taylor, M.D., Molecular diagnostics of CNS embryonal tumors (2010) Acta Neuropathol, 120, pp. 553-566. , doi:10.1007/s00401-010-0751-5Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method (2001) Methods, 25, pp. 402-408. , doi:10.1006/meth.2001.1262Pietsch, T., Scharmann, T., Fonatsch, C., Schmidt, D., Ockler, R., Freihoff, D., Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system (1994) Cancer Res, 54, pp. 3278-3287Breitling, R., Armengaud, P., Amtmann, A., Herzyk, P., Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments (2004) FEBS Lett, 573, pp. 83-92. , doi:10.1016/j.febslet.2004.07.055Gautier, L., Cope, L., Bolstad, B.M., Irizarry, R.A., Affy - analysis of Affymetrix GeneChip data at the probe level (2004) Bioinformatics, 20, pp. 307-315. , doi:10.1093/bioinformatics/btg405Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S., Bioconductor: open software development for computational biology and bioinformatics (2004) Genome Biol, 5, pp. R80Zhou, J., Tian, Y., Li, J., Lu, B., Sun, M., Zou, Y., miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2 (2013) Biochem Biophys Res Commun, 433 (2), pp. 207-212. , doi:10.1016/j.bbrc.2013.02.084Birks, D.K., Barton, V.N., Donson, A.M., Handler, M.H., Vibhakar, R., Foreman, N.K., Survey of MicroRNA expression in pediatric brain tumors (2011) Pediatr Blood Cancer, 56 (2), pp. 211-216. , doi:10.1002/pbc.22723Huang, Y.W., Liu, J.C., Deatherage, D.E., Luo, J., Mutch, D.G., Goodfellow, P.J., Epigenetic repression of microRNA-129-2 leads to upregulation of SOX4 oncogene in endometrial cancer (2009) Cancer Res, 69 (23), pp. 9038-9046. , doi:10.1158/0008-5472.CAN-09-1499Shen, R., Pan, S., Qi, S., Lin, X., Cheng, S., Epigenetic repression of microRNA-129-2 leads to upregulation of SOX4 in gastric cancer (2010) Biochem Biophys Res Commun, 394 (4), pp. 1047-1052. , doi:10.1016/j.bbrc.2010.03.121Neben, K., Korshunov, A., Benner, A., Wrobel, G., Hahn, M., Kokocinski, F., Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival (2004) Cancer Res, 64 (9), pp. 3103-3111. , doi:10.1158/0008-5472.CAN-03-3968de Bont, J.M., Kros, J.M., Passier, M.M., Reddingius, R.E., Sillevis Smitt, P.A., Luider, T.M., Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis (2008) Neuro Oncol, 10 (5), pp. 648-660. , doi:10.1215/15228517-2008-032Garzia, L., Andolfo, I., Cusanelli, E., Marino, N., Petrosino, G., De Martino, D., MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma (2009) PLoS ONE, 4, p. 4998. , doi:10.1371/journal.pone.0004998Gokhale, A., Kunder, R., Goel, A., Sarin, R., Moiyadi, A., Shenoy, A., Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway (2010) J Cancer Res Ther, 6, pp. 521-529. , doi:10.4103/0973-1482.77072de Antonellis, P., Medaglia, C., Cusanelli, E., Andolfo, I., Liguori, L., De Vita, G., MiR-34a targeting of notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma (2011) PLoS ONE, 6 (9), pp. e24584. , doi:10.1371/journal.pone.0024584Grunder, E., D'Ambrosio, R., Fiaschetti, G., Abela, L., Arcaro, A., Zuzak, T., MicroRNA-21 suppression impedes medulloblastoma cell migration (2011) Eur J Cancer, 47, pp. 2479-2490. , doi:10.1016/j.ejca.2011.06.041Uziel, T., Karginov, F.V., Xie, S., Parker, J.S., Wang, Y.D., Gajjar, A., The miR-17 92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma (2009) Proc Natl Acad Sci USA, 106, pp. 2812-2817. , doi:10.1073/pnas.0809579106Chédotal, A., Kerjan, G., Moreau-Fauvarque, C., The brain within the tumor: new roles for axon guidance molecules in cancers (2005) Cell Death Differ, 12 (8), pp. 1044-1056. , doi:10.1038/sj.cdd.4401707Aref, D., Moffatt, C.J., Agnihotri, S., Ramaswamy, V., Dubuc, A.M., Northcott, P.A., Canonical TGF-b pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development (2013) Brain Pathol, 23, pp. 178-191. , doi:10.1111/j.1750-3639.2012.00631.xLuo, X., Liu, J., Cheng, S.Y., The role of microRNAs during the genesis of medulloblastoma induced by the hedgehog pathway (2011) Biomed Res, 25 (1), pp. 42-48. , doi:10. 1016/S1674-8301(11)Northcott, P.A., Shih, D.J., Peacock, J., Garzia, L., Morrissy, A.S., Zichner, T., Subgroup-specific structural variation across 1,000 medulloblastoma genomes (2012) Nature, 488 (7409), pp. 49-56. , doi:10.1038/nature11327Song, G., Wang, L., miR-433 and miR-127 arise from independent overlapping primary transcripts encoded by the miR-433-127 locus (2008) PLoS ONE, 3, pp. e3574. , doi:10.1371/journal.pone.0003574Remke, M., Hielscher, T., Korshunov, A., Northcott, P.A., Bender, S., Kool, M., FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma (2011) J Clin Oncol, 29 (29), pp. 3852-3861. , doi:10.1200/JCO.2011.36.2798Edgar, R., Domrachev, M., Lash, A.E., Gene expression omnibus: NCBI gene expression and hybridization array data repository (2002) Nucleic Acids Res, 30, pp. 207-210. , doi:10.1093/nar/30.1.207Yu, S., Wang, X., Ng, C.F., Chen, S., Chan, F.L., ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer (2007) Cancer Res, 67 (10), pp. 4904-4914. , doi:10.1158/0008-5472.CAN-06-3855Mancuso, M., Leonardi, S., Giardullo, P., Pasquali, E., Borra, F., Stefano, I.D., The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways (2011) Cancer Lett, 308 (2), pp. 197-202. , doi:10.1016/j.canlet.2011.05.004da Rocha, S.T., Edwards, C.A., Ito, M., Ogata, T., Ferguson-Smith, A.C., Genomic imprinting at the mammalian Dlk1-Dio3 domain (2008) Trends Genet, 24, pp. 306-316. , doi:10.1016/j.tig.2008.03.011Lin, S.P., Youngson, N., Takada, S., Seitz, H., Reik, W., Paulsen, M., Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12 (2003) Nat Genet, 35, pp. 97-102. , doi:10.1038/ng1233Takada, S., Paulsen, M., Tevendale, M., Tsai, C.E., Kelsey, G., Cattanach, B.M., Epigenetic analysis of the Dlk1-Gtl2 imprinted domain on mouse chromosome implications for imprinting control from comparison with Igf2-H19 (2002) Hum Mol Genet, 12, pp. 77-86. , doi:10.1093/hmg/11.1.77Kagami, M., O'Sullivan, M.J., Green, A.J., Watabe, Y., Arisaka, O., Masawa, N., The IG-DMR and the MEG3-DMR at human chromosome 14q32 2: hierarchical interaction and distinct functional properties as imprinting control centers (2010) PLoS Genet, 6, pp. e1000992. , doi:10.1371/journal.pgen.1000992Diede, S.J., Guenthoer, J., Geng, L.N., Mahoney, S.E., Marotta, M., Olson, J.M., DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences (2010) Proc Natl Acad Sci U S A, 107 (1), pp. 234-239. , doi:10.1073/pnas.0907606106Thayanithy, V., Park, C., Sarver, A.L., Kartha, R.V., Korpela, D.M., Graef, A.J., Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines (2012) PLoS ONE, 7 (9), pp. e43720. , doi:10.1371/journal.pone.0043720Pierson, J., Hostager, B., Fan, R., Vibhakar, R., Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma (2008) J Neurooncol, 90, pp. 1-7. , doi:10.1007/s11060-008-9624-3Li, K.K., Pang, J.C., Ching, A.K., Wong, C.K., Kong, X., Wang, Y., miR-124 is frequently down-regulated in meduloblastoma and is a negative regulator of SLC16A1 (2009) Hum Pathol, 40 (9), pp. 1234-1243. , doi:10.1016/j.humpath.2009.02.003Ferretti, E., De Smaele, E., Miele, E., Laneve, P., Pó, A., Pelloni, M., Concerted miRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells (2008) EMBO J, 27, pp. 2616-2627. , doi:10.1038/emboj.2008.172Venkataraman, S., Alimova, I., Fan, R., Harris, P., Foreman, N., Vibhakar, R., MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence (2010) PLoS ONE, 5 (6), pp. e10748. , doi:10.1371/journal.pone.0010748Genovesi, L.A., Carter, K.W., Gottardo, N.G., Giles, K.M., Dallas, P.B., Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells (2011) PLoS ONE, 6 (9), pp. e23935. , doi:10.1371/journal.pone.0023935Weeraratne, S.D., Amani, V., Neiss, A., Teider, N., Scott, D.K., Pomeroy, S.L., miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma (2011) Neuro Oncol, 13 (2), pp. 165-175. , doi:10.1093/neuonc/noq179Lv, S.Q., Kim, Y.H., Giulio, F., Shalaby, T., Nobusawa, S., Yang, H., Genetic alterations in MicroRNAs in medulloblastomas (2012) Brain Pathol, 22, pp. 230-239. , doi:10.1111/j.1750-3639.2011.00523.xWang, X.M., Zhang, S.F., Cheng, Z.Q., Peng, Q.Z., Hu, J.T., Gao, L.K., MicroRNA383 regulates expression of PRDX3 in human medulloblastomas (2012) Zhonghua Bing Li Xue Za Zhi, 41 (8), pp. 547-552. , doi:10.3760/cma.j.issn.0529-5807.2012.08.009Li, K.K.W., Pang, J.C.S., Lau, K.M., Zhou, L., Mao, Y., Wang, Y., MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3) (2013) Brain Pathol, 23 (4), pp. 413-425. , doi:10.1111/bpa.12014Weeraratne, S.D., Amani, V., Teider, N., Pierre-Francois, J., Winter, D., Kye, M.J., Pleiotropic effects of miR-183 96 182 converge to regulate cell survival, proliferation and migration in meduloblastoma (2012) Acta Neuropathol, 123, pp. 539-552. , doi:10.1007/s00401-012-0969-5Venkataraman, S., Birks, D.K., Balakrishnan, I., Alimova, I., Harris, P.S., Patel, P.R., MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma (2013) J Biol Chem, 228 (3), pp. 1918-1928. , doi:10.1074/jbc.M112.396762Wei, L., Yan-hua, G., Teng-fei, C., Xiao-zhong, P., Jian-gang, Y., Zhen-yu, M., Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas (2009) Chin Med J, 122 (20), pp. 2405-241

Impaired presynaptic function and elimination of synapses at premature stages during postnatal development of the cerebellum in the absence of CALEB (CSPG5/neuroglycan C)

Chicken acidic leucine-rich EGF-like domain-containing brain protein (CALEB), also known as chondroitin sulfate proteoglycan (CSPG)5 or neuroglycan C, is a neural chondroitin sulfate-containing and epidermal growth factor (EGF)-domain-containing transmembrane protein that is implicated in synaptic maturation. Here, we studied the role of CALEB within the developing cerebellum. Adult CALEB-deficient mice displayed impaired motor coordination in Rota-Rod experiments. Analysis of the neuronal connectivity of Purkinje cells by patch-clamp recordings demonstrated impairments of presynaptic maturation of inhibitory synapses. GABAergic synapses on Purkinje cells revealed decreased evoked amplitudes, altered paired-pulse facilitation and reduced depression after repetitive stimulation at early postnatal but not at mature stages. Furthermore, the elimination of supernumerary climbing fiber synapses on Purkinje cells was found to occur at earlier developmental stages in the absence of CALEB. For example, at postnatal day 8 in wild-type mice, 54% of Purkinje cells had three or more climbing fiber synapses in contrast to mutants where this number was decreased to less than 25%. The basic properties of the climbing fiber Purkinje cell synapse remained unaffected. Using Sholl analysis of dye-injected Purkinje cells we revealed that the branching pattern of the dendritic tree of Purkinje cells was not impaired in CALEB-deficient mice. The alterations observed by patch-clamp recordings correlated with a specific pattern and timing of expression of CALEB in Purkinje cells, i.e. it is dynamically regulated during development from a high chondroitin sulfate-containing form to a non-chondroitin sulfate-containing form. Thus, our results demonstrated an involvement of CALEB in the presynaptic differentiation of cerebellar GABAergic synapses and revealed a new role for CALEB in synapse elimination in Purkinje cells

High expression of human carboxypeptidase M in Pichia pastoris: Purification and partial characterization

Carboxypeptidase M (CPM) is an extracellular glycosylphosphatidyl-inositol-anchored membrane glycoprotein, which removes the C-terminal basic residues, lysine and arginine, from peptides and proteins at neutral pH. CPM plays an important role in the control of peptide hormones and growth factor activity on the cell surface. The present study was carried out to clone and express human CPM in the yeast Pichia pastoris in order to evaluate the importance of this enzyme in physiological and pathological processes. The cDNA for the enzyme was amplified from total placental RNA by RT-PCR and cloned in the vector pPIC9, which uses the methanol oxidase promoter and drives the expression of high levels of heterologous proteins in P. pastoris. The cpm gene, after cloning and transfection, was integrated into the yeast genome, which produced the active protein. The recombinant protein was secreted into the medium and the enzymatic activity was measured using the fluorescent substrate dansyl-Ala-Arg. The enzyme was purified by a two-step protocol including gel filtration and ion-exchange chromatography, resulting in a 1753-fold purified active protein (16474 RFU mg protein-1 min-1). This purification protocol permitted us to obtain 410 mg of the purified protein per liter of fermentation medium. SDS-PAGE showed that recombinant CPM migrated as a single band with a molecular mass similar to that of native placental enzyme (62 kDa), suggesting that the expression of a glycosylated protein had occurred. These results demonstrate for the first time the establishment of a method using P. pastoris to express human CPM necessary to the development of specific antibodies and antagonists, and the analysis of the involvement of this peptidase in different physiological and pathological processe

High expression of human carboxypeptidase M in Pichia pastoris: Purification and partial characterization

Carboxypeptidase M (CPM) is an extracellular glycosylphosphatidyl-inositol-anchored membrane glycoprotein, which removes the C-terminal basic residues, lysine and arginine, from peptides and proteins at neutral pH. CPM plays an important role in the control of peptide hormones and growth factor activity on the cell surface. The present study was carried out to clone and express human CPM in the yeast Pichia pastoris in order to evaluate the importance of this enzyme in physiological and pathological processes. The cDNA for the enzyme was amplified from total placental RNA by RT-PCR and cloned in the vector pPIC9, which uses the methanol oxidase promoter and drives the expression of high levels of heterologous proteins in P. pastoris. The cpm gene, after cloning and transfection, was integrated into the yeast genome, which produced the active protein. The recombinant protein was secreted into the medium and the enzymatic activity was measured using the fluorescent substrate dansyl-Ala-Arg. The enzyme was purified by a two-step protocol including gel filtration and ion-exchange chromatography, resulting in a 1753-fold purified active protein (16474 RFU mg protein-1 min-1). This purification protocol permitted us to obtain 410 mg of the purified protein per liter of fermentation medium. SDS-PAGE showed that recombinant CPM migrated as a single band with a molecular mass similar to that of native placental enzyme (62 kDa), suggesting that the expression of a glycosylated protein had occurred. These results demonstrate for the first time the establishment of a method using P. pastoris to express human CPM necessary to the development of specific antibodies and antagonists, and the analysis of the involvement of this peptidase in different physiological and pathological processe

[Ga-68]Ga-Pentixafor and Sodium [F-18]Fluoride PET Can Non-Invasively Identify and Monitor the Dynamics of Orthodontic Tooth Movement in Mouse Model

The cellular and molecular mechanisms of orthodontic tooth movement (OTM) are not yet fully understood, partly due to the lack of dynamical datasets within the same subject. Inflammation and calcification are two main processes during OTM. Given the high sensitivity and specificity of [68Ga]Ga-Pentixafor and Sodium [18F]Fluoride (Na[18F]F) for inflammation and calcification, respectively, the aim of this study is to assess their ability to identify and monitor the dynamics of OTM in an established mouse model. To monitor the processes during OTM in real time, animals were scanned using a small animal PET/CT during week 1, 3, and 5 post-implantation, with [68Ga]Ga-Pentixafor and Na[18F]F. Both tracers showed an increased uptake in the region of interest compared to the control. For [68Ga]Ga-Pentixafor, an increased uptake was observed within the 5-week trial, suggesting the continuous presence of inflammatory markers. Na[18F]F showed an increased uptake during the trial, indicating an intensification of bone remodelling. Interim and end-of-experiment histological assessments visualised increased amounts of chemokine receptor CXCR4 and TRAP-positive cells in the periodontal ligament on the compression side. This approach establishes the first in vivo model for periodontal remodelling during OTM, which efficiently detects and monitors the intricate dynamics of periodontal ligament